Predict your next investment

Corporation
genusplc.com

See what CB Insights has to offer

Partners & Customers

2

About Genus

Genus provides farmers with superior genetics, so they can efficiently produce high-quality meat and milk. The company applies biotechnology to advance the science of animal breeding and genetic improvement. Genus's technology is applicable to all livestock species and is currently commercializing it in dairy, beef and pork.

Genus Headquarter Location

Belvedere House, Basing View

Hamphire, RG21 4HG,

United Kingdom

+44(0)1256 347100

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Genus News

Long Term Genetic Collaboration Between PIC and Olymel LP in Canada

Mar 1, 2022

Long Term Genetic Collaboration Between PIC and Olymel LP in Canada Long Term Genetic Collaboration Between PIC and Olymel LP in Canada BASINGSTOKE, United Kingdom – Genus plc (LSE: GNS) is pleased to announce that PIC has entered into definitive agreements with Olymel LP, a leader in the Canadian agrifood industry, for provision of genetic products and services in connection with the Olymel’s AlphaGene porcine genetic improvement program. Olymel is the largest porcine producer in Canada with capacity for over 185,000 pigs per week and under the transaction, PIC has acquired all intellectual property in Olymel’s elite porcine genetics for a consideration of Canadian $25 million. The parties have also entered into an exclusive long term genetics collaboration agreement, where PIC will supply elite germplasm and manage the ongoing genetic improvement of Olymel’s AlphaGene genetics. Other commercial terms of the transaction are confidential. PIC will use its proprietary genetics, technologies and services to accelerate genetic gain consistent with Olymel’s strategic genetic goals. Olymel will continue to distribute the AlphaGene genetics through its internal multiplication program and to its independent producer herds in Canada. The collaboration combines PIC’s expertise in porcine genetic improvement with Olymel’s leading porcine production facilities, enabling Olymel’s customers to benefit from improved AlphaGene health, efficiency and breakthrough technologies. The collaboration with Olymel increases PIC’s footprint in the Canadian porcine genetics market and will better allow both parties to serve pork producers across Canada. Bill Christianson, COO of PIC, said: “We are excited to be working with Olymel, the leading Canadian pig producer, with a focus on differentiated product quality. The complementary nature of PIC’s leading genetics, and Olymel’s significant production facilities will benefit customers of AlphaGene genetics throughout the porcine production pyramid.” Paul Beauchamp First Vice-president, Olymel LP added: “PIC is a world leader in porcine genetic improvement, demonstrating the improved value, health and efficiency of animals from their genetics programs year after year. With this collaboration we intend to accelerate performance of our AlphaGene genetics, providing increased value for all of our customers.” About Genus Genus advances animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors. Genus’s worldwide sales are made in over 80 countries under the trademarks ‘ABS’ (dairy and beef cattle) and ‘PIC’ (pigs) and comprise semen, embryos and breeding animals with superior genetics to those animals currently in farms. Genus’s customers’ animals produce offspring with greater production efficiency and quality, and our customers use them to supply the global dairy and meat supply chains. Genus’s competitive edge comes from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network. Headquartered in Basingstoke, United Kingdom, Genus companies operate in over 24 countries on six continents, with research laboratories located in Madison, Wisconsin, USA. About Olymel Olymel is Canada’s leader in the production, processing and distribution of pork and poultry meats. The company has made feeding the world its mission, which it pursues passionately with products of impeccable quality. It employs over 14,000 people and has production and processing facilities in Quebec, Ontario, Alberta, Saskatchewan and New Brunswick. Olymel exports nearly a third of its total sales. Its annual sales reach $4.5 billion. The company markets its products mainly under the Olymel, Lafleur, Flamingo, La Fernandière, Pinty’s, Tour Eiffel and F. Ménard brands.

Genus Acquisitions

2 Acquisitions

Genus acquired 2 companies. Their latest acquisition was In Vitro Brasil on April 19, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/19/2017

$99M

Acquired

1

2/16/2015

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/19/2017

2/16/2015

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Sources

1

10

Genus Partners & Customers

2 Partners and customers

Genus has 2 strategic partners and customers. Genus recently partnered with Tropic Biosciences on September 9, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

9/30/2020

Partner

United Kingdom

Genus Plc and Tropic Biosciences announce strategic collaboration

Genus Plc. , a world leader in animal genetic improvement , and Tropic Biosciences , the pioneering agricultural-biotechnology company , today announce a collaboration to explore the application of Tropic Biosciences 's Gene Editing induced Gene Silencing technology in porcine and bovine genetics .

1

6/29/2019

Partner

China

Subscribe to see more

Subscribe to see more

10

Date

9/30/2020

6/29/2019

Type

Partner

Partner

Business Partner

Country

United Kingdom

China

News Snippet

Genus Plc and Tropic Biosciences announce strategic collaboration

Genus Plc. , a world leader in animal genetic improvement , and Tropic Biosciences , the pioneering agricultural-biotechnology company , today announce a collaboration to explore the application of Tropic Biosciences 's Gene Editing induced Gene Silencing technology in porcine and bovine genetics .

Subscribe to see more

Subscribe to see more

Sources

1

10

Genus Team

1 Team Member

Genus has 1 team member, including former Managing Director, John Berry.

Name

Work History

Title

Status

John Berry

Managing Director

Former

Name

John Berry

Work History

Title

Managing Director

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.